Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...

Merck (NYSE:MRK) has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite ...

Merck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...

In a strategic move to enhance its manufacturing capabilities, Merck has inaugurated a new $1 billion vaccine manufacturing facility in Durham, North Carolina. This facility is part of Merck’s ...

In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to strengthen its U.S. manufacturing capabilities. The facility incorporates ...

Pharmaceutical giant Merck is set to close its plant in Northumberland County, PA, impacting 163 workers. However, it remains committed to Upper Gwynedd Township and Pennsylvania at-large. The company ...

The investment will be used to improve R&D infrastructure to develop new treatments and implement new technologies to improve ...

Last week, I had the honor of presenting Merck's current holding report to the KSU Managed Investment Fund LLC alongside Jonathan Melton. This experience was not just a presentation, but a ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...

The decision was based on the lack of substantial evidence to support the claims. In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to ...